ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
0.00
0.00%
S&P ASX All Technology
0.00
0.00%
Brent Oil
77.64
-0.89%
US Dollar vs AUD
1.59096
-0.20%
Bitcoin
104,588.09
0.92%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nymox Pharmaceutical Corp (NYMX)

  7. Nymox Pharmaceutical Corp (NYMX) News

NYMX

Nymox Pharmaceutical (NYMX)

Nymox Pharmaceutical Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NYMX
DateTimeSourceHeadlineSymbolCompany
30/08/202407:26Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:NYMXNymox Pharmaceutical Corp
14/05/202406:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
29/03/202404:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
10/11/202304:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
07/11/202301:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
27/10/202306:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
09/09/202300:13Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NYMXNymox Pharmaceutical Corp
30/08/202305:34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
03/08/202303:40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
01/08/202303:54Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
26/07/202306:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
26/07/202306:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
26/07/202300:33GlobeNewswire Inc.Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial ResultsNASDAQ:NYMXNymox Pharmaceutical Corp
19/07/202300:45GlobeNewswire Inc.Nymox Reports on U.S. Patent IssuancesNASDAQ:NYMXNymox Pharmaceutical Corp
14/07/202300:16GlobeNewswire Inc.Nymox UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
13/07/202307:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
12/07/202323:30GlobeNewswire Inc.Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of NymoxNASDAQ:NYMXNymox Pharmaceutical Corp
08/07/202307:02GlobeNewswire Inc.NYMOX UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
06/07/202308:11GlobeNewswire Inc.Nymox Delisting from NASDAQNASDAQ:NYMXNymox Pharmaceutical Corp
30/06/202307:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NYMXNymox Pharmaceutical Corp
30/06/202307:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
30/06/202306:25Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:NYMXNymox Pharmaceutical Corp
30/06/202306:24Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:NYMXNymox Pharmaceutical Corp
28/06/202307:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NYMXNymox Pharmaceutical Corp
27/06/202300:28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NYMXNymox Pharmaceutical Corp
19/05/202306:14Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NYMXNymox Pharmaceutical Corp
13/05/202306:53Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NYMXNymox Pharmaceutical Corp
11/05/202300:00GlobeNewswire Inc.Nymox Provides Current UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
03/04/202323:30GlobeNewswire Inc.Nymox Provides Corporate UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
01/04/202307:25Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:NYMXNymox Pharmaceutical Corp
 Showing the most relevant articles for your search:NASDAQ:NYMX

Your Recent History

EU
TFING
Euronext Transatlantic F...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads